Ensysce Biosciences, Inc. (ENSC) Financials
ENSC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.7 million | 3.4 million |
2023-09-30 | 3.2 million | 2.1 million |
2023-06-30 | 6.4 million | 2.6 million |
2023-03-31 | 3.9 million | 4.1 million |
ENSC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -1.8 million | 628936 |
2023-09-30 | -2.3 million | 55674 |
2023-06-30 | -3.1 million | 77417 |
2023-03-31 | -3.6 million | 117133 |
ENSC Net Income
No data available :(
ENSC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.1 million | - | - |
2023-09-30 | 1.5 million | - | 2732 |
2023-06-30 | 3.8 million | - | 10926 |
2023-03-31 | 1.4 million | - | 19120 |
ENSC Shares Outstanding
ENSC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 2.2 million | 1.4 million | 2 |
2023-09-30 | - | 1.9 million | 1.2 million | - |
2023-06-30 | - | 1.6 million | 1.1 million | - |
2023-03-31 | - | 1.8 million | 1.6 million | - |
ENSC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 515032 | 3.4 million |
2023-09-30 | - | - |
2023-06-30 | 490472 | 1.6 million |
2023-03-31 | 789635 | 1.8 million |
ENSC
Price: $0.55
52 week price:
Earnings Per Share: -4.69 USD
P/E Ratio: -0.68
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 86482
Market Capitalization: 5.5 million